NordiNet® outcomes research
NordiNet® is the flexible internet-based database patient registry for physicians treating patients with disorders related to growth hormone and other endocrine disorders. The updated NordiNet® 3 version will be launched in Europe (3.0) in 2008 and in the US (3.1) and Japan (3.2) in 2009.
The three dimensions of NordiNet® are:
NordiNet® includes data from over 6000 patients from more than 300 clinics worldwide.
The main objective of NordiNet® is to support patient care for the benefit of patients and clinicians. From a medical point of view NordiNet® based research inclusive of IOS will provide information on Norditropin® efficacy and safety.
